RAYMOND JAMES & ASSOCIATES - INARI MED INC ownership

INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 155 filers reported holding INARI MED INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of INARI MED INC
ValueSharesWeighting
Q4 2022$238,477
-24.3%
3,752
-13.4%
0.00%
Q3 2022$315,000
+5.0%
4,335
-1.9%
0.00%
Q2 2022$300,000
-24.6%
4,418
+0.7%
0.00%
Q1 2022$398,000
+1.3%
4,386
+1.8%
0.00%
Q4 2021$393,000
-41.3%
4,310
-47.9%
0.00%
-100.0%
Q3 2021$670,000
-60.8%
8,266
-54.9%
0.00%
-50.0%
Q2 2021$1,709,000
-20.3%
18,322
-8.6%
0.00%0.0%
Q1 2021$2,144,000
+190.5%
20,037
+137.1%
0.00%
+100.0%
Q4 2020$738,0008,4500.00%
Other shareholders
INARI MED INC shareholders Q4 2020
NameSharesValueWeighting ↓
Darsana Capital Partners LP 1,475,000$137,588,0003.91%
Affinity Asset Advisors, LLC 85,000$7,929,0002.84%
Parian Global Management LP 49,800$4,645,0001.99%
AlpInvest Partners B.V. 27,960$2,608,0001.28%
Sio Capital Management, LLC 46,332$4,322,0001.07%
HARBOURVEST PARTNERS LLC 88,598$8,264,0000.79%
HAMILTON LANE ADVISORS LLC 26,403$2,463,0000.77%
Pier Capital, LLC 76,708$7,155,0000.72%
Lisanti Capital Growth, LLC 46,035$4,294,0000.53%
NEXT CENTURY GROWTH INVESTORS LLC 66,822$6,233,0000.49%
View complete list of INARI MED INC shareholders